EGFR and cancer: Furthermore, the GSEA identified that one of the variants rs6996585 was associated with many pathways related to cellular growth or cancer and the ERBB-MAPK signalling pathway was the most significantly enriched with its related signals (Fig. 2f and Supplementary Table 8).